Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre.

Saved in:
Bibliographic Details
Title: Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre.
Authors: Lobo N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nogueras-Gonzalez GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abraham P; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Source: BJU international [BJU Int] 2022 Sep; Vol. 130 (3), pp. 323-330. Date of Electronic Publication: 2021 Dec 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1464-410X
DOI:10.1111/bju.15661